Skip to main content

Table 2 Outcome of FPMSC isolation and expansion under GMP requirements

From: Optimizing mesenchymal stem cell therapy: from isolation to GMP-compliant expansion for clinical application

Sample ID

W455623000021

W455623000032

W455623000038

W455623000040

Average

Donor age

23

42

44

50

39.7 ± 11.7

Donor sex

Male

Female

Male

Female

 

Vol. starting material (ml)

20

19.5

10

24

17 ± 3.82

Initial number of cell (x106)

11

2.5

5.29

3.19

5.48 ± 3.83

Initial viability (%, > 70%)

83

80

71

77

78 ± 0.05

Time until 1st passage (days)

8

14

10

10

10.5 ± 2.52

Total cells at P1 (x107)

1.43

1.20

1.23

1.24

1.28 ± 0.10

Passage viability (%, > 70%)

99

89

88

96

93 ± 0.05

Total cell harvest (x108)

1.55

1.05

1.00

1.01

1.15 ± 0.27

Harvest time (days)

12

20

20

16

17 ± 3.83

Cell viability at final harvest (%)

100

96

95

97

97 ± 0.02